Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study.
Désirée Mfm van der HeijdeAtul A DeodharJames C WeiEdit DrescherDona FleishakerThijs HendrikxDavid LiSujatha MenonKeith S KanikPublished in: Annals of the rheumatic diseases (2017)
NCT01786668.